These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 17234133

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
    Pardridge WM.
    Bioconjug Chem; 2008 Jul; 19(7):1327-38. PubMed ID: 18547095
    [Abstract] [Full Text] [Related]

  • 3. Biopharmaceutical drug targeting to the brain.
    Pardridge WM.
    J Drug Target; 2010 Apr; 18(3):157-67. PubMed ID: 20064077
    [Abstract] [Full Text] [Related]

  • 4. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM.
    Curr Opin Pharmacol; 2006 Oct; 6(5):494-500. PubMed ID: 16839816
    [Abstract] [Full Text] [Related]

  • 5. Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier.
    Boado RJ, Zhang Y, Zhang Y, Pardridge WM.
    Biotechnol Bioeng; 2007 Aug 15; 97(6):1376-86. PubMed ID: 17286273
    [Abstract] [Full Text] [Related]

  • 6. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
    Pardridge WM, Boado RJ.
    Methods Enzymol; 2012 Aug 15; 503():269-92. PubMed ID: 22230573
    [Abstract] [Full Text] [Related]

  • 7. Blood-brain barrier delivery.
    Pardridge WM.
    Drug Discov Today; 2007 Jan 15; 12(1-2):54-61. PubMed ID: 17198973
    [Abstract] [Full Text] [Related]

  • 8. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound.
    Kinoshita M, McDannold N, Jolesz FA, Hynynen K.
    Biochem Biophys Res Commun; 2006 Feb 24; 340(4):1085-90. PubMed ID: 16403441
    [Abstract] [Full Text] [Related]

  • 9. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ, Zhang Y, Zhang Y, Pardridge WM.
    Biotechnol Bioeng; 2007 Feb 01; 96(2):381-91. PubMed ID: 16937408
    [Abstract] [Full Text] [Related]

  • 10. Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horse.
    Boado RJ, Hui EK, Lu JZ, Pardridge WM.
    J Pharmacol Exp Ther; 2010 Jun 01; 333(3):961-9. PubMed ID: 20233799
    [Abstract] [Full Text] [Related]

  • 11. Targeted delivery of protein and gene medicines through the blood-brain barrier.
    Pardridge WM.
    Clin Pharmacol Ther; 2015 Apr 01; 97(4):347-61. PubMed ID: 25669455
    [Abstract] [Full Text] [Related]

  • 12. Delivery of peptides to the brain: emphasis on therapeutic development.
    Banks WA.
    Biopolymers; 2008 Apr 01; 90(5):589-94. PubMed ID: 18335425
    [Abstract] [Full Text] [Related]

  • 13. Modern methods for delivery of drugs across the blood-brain barrier.
    Chen Y, Liu L.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):640-65. PubMed ID: 22154620
    [Abstract] [Full Text] [Related]

  • 14. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L.
    Drug Discov Today; 2008 Dec 15; 13(23-24):1099-106. PubMed ID: 18848640
    [Abstract] [Full Text] [Related]

  • 15. Blood-brain barrier drug targeting: the future of brain drug development.
    Pardridge WM.
    Mol Interv; 2003 Mar 15; 3(2):90-105, 51. PubMed ID: 14993430
    [Abstract] [Full Text] [Related]

  • 16. Drug targeting to the brain.
    Pardridge WM.
    Pharm Res; 2007 Sep 15; 24(9):1733-44. PubMed ID: 17554607
    [Abstract] [Full Text] [Related]

  • 17. Neurotrophins, neuroprotection and the blood-brain barrier.
    Pardridge WM.
    Curr Opin Investig Drugs; 2002 Dec 15; 3(12):1753-7. PubMed ID: 12528312
    [Abstract] [Full Text] [Related]

  • 18. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
    Gaillard PJ, de Boer AG.
    Methods Mol Biol; 2008 Dec 15; 437():161-75. PubMed ID: 18369968
    [Abstract] [Full Text] [Related]

  • 19. A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery.
    Boado RJ.
    Drug News Perspect; 2008 Nov 15; 21(9):489-503. PubMed ID: 19180267
    [Abstract] [Full Text] [Related]

  • 20. Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology.
    Pardridge WM.
    BioDrugs; 2017 Dec 15; 31(6):503-519. PubMed ID: 29067674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.